Roivant Sciences Ltd.
Simbols: ROIV
NASDAQ
11.25
USDTirgus cena šodien
2.0826
P/E koeficients
0.0316
PEG koeficients
9.07B
MRK Cap
- 0.00%
DIV ienesīgums
Roivant Sciences Ltd. (ROIV) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1692.1 | 2074 | 2055 | |||||
balance-sheet.row.short-term-investments | 0 | 15.3 | 13.6 | 0 | |||||
balance-sheet.row.net-receivables | 0 | 32.7 | 6.7 | 13.8 | |||||
balance-sheet.row.inventory | 0 | 2.8 | -16.5 | 63.9 | |||||
balance-sheet.row.other-current-assets | 0 | 121.8 | 82.2 | 54.3 | |||||
balance-sheet.row.total-current-assets | 0 | 1798.6 | 2146.5 | 2187 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 92.3 | 86.9 | 77 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.long-term-investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.other-non-current-assets | 0 | 49.5 | 25.8 | 36.1 | |||||
balance-sheet.row.total-non-current-assets | 0 | 591 | 438.6 | 402.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.account-payables | 0 | 37.8 | 34.6 | 20.6 | |||||
balance-sheet.row.short-term-debt | 0 | 52.4 | 11.4 | 12.3 | |||||
balance-sheet.row.tax-payables | 0 | 0.5 | 0.7 | 0.2 | |||||
balance-sheet.row.long-term-debt-total | 0 | 429 | 272.5 | 232.7 | |||||
Deferred Revenue Non Current | 0 | 0 | 13.7 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 15.1 | 128.2 | 180.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 509.6 | 339.3 | 308.7 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 22.5 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 65.2 | 73.9 | 74.7 | |||||
balance-sheet.row.total-liab | 0 | 782 | 546.2 | 527.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | 0 | -3772.8 | -2763.7 | -1918.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.6 | -0.9 | 1.4 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 5383 | 4803.6 | 3714.8 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 1607.6 | 2038.9 | 1797.8 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.minority-interest | 0 | 449.8 | 404.5 | 264.2 | |||||
balance-sheet.row.total-equity | 0 | 2057.4 | 2443.4 | 2062 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.total-debt | 0 | 481.4 | 283.9 | 245 | |||||
balance-sheet.row.net-debt | 0 | -1195.4 | -1776.5 | -1810.1 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1115.5 | -924.1 | -900.2 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 18.9 | 5.9 | 0 | |||||
cash-flows.row.deferred-income-tax | 0 | -4.4 | -5.9 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 217.8 | 565 | 85 | |||||
cash-flows.row.change-in-working-capital | 0 | 6.3 | 15.7 | 71.9 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 4.4 | 15.4 | 3.8 | |||||
cash-flows.row.other-working-capital | 0 | 2 | 0.3 | 68.2 | |||||
cash-flows.row.other-non-cash-items | 0 | 33.4 | -334.3 | 191.2 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.acquisitions-net | 0 | 107.9 | 0 | 0 | |||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -28.3 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 320.2 | 0 | |||||
cash-flows.row.other-investing-activites | 0 | -139.4 | 0.6 | 2.4 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -44.3 | 303.3 | -31.7 | |||||
cash-flows.row.debt-repayment | 0 | -30.1 | -21.6 | 0 | |||||
cash-flows.row.common-stock-issued | 0 | 379.7 | 313.4 | 455.8 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0.3 | 0 | -0.1 | |||||
cash-flows.row.dividends-paid | 0 | -162.7 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | 312.3 | 15 | 0.6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 499.5 | 306.8 | 456.3 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 6.3 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | -381.9 | -67.6 | -127.6 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 1692.1 | 2074 | 2141.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2074 | 2141.7 | 2269.3 | |||||
cash-flows.row.operating-cash-flow | 0 | -843.4 | -677.7 | -552.1 | |||||
cash-flows.row.capital-expenditure | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.free-cash-flow | 0 | -856.1 | -695.2 | -557.9 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 61.3 | 55.3 | 23.8 | |||||
income-statement-row.row.cost-of-revenue | 0 | 13.1 | 9 | 2.1 | |||||
income-statement-row.row.gross-profit | 0 | 48.2 | 46.3 | 21.7 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.operating-expenses | 0 | 1125.7 | 1258.1 | 496.5 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1138.8 | 1267 | 498.6 | |||||
income-statement-row.row.interest-income | 0 | 32.2 | 0.4 | 1.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.total-operating-expenses | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | -30 | -288.1 | 560.4 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | -1077.6 | -1211.7 | -1070.9 | |||||
income-statement-row.row.income-before-tax | 0 | -1224.8 | -923.7 | -898.5 | |||||
income-statement-row.row.income-tax-expense | 0 | 5.2 | 0.4 | 1.7 | |||||
income-statement-row.row.net-income | 0 | -1230 | -924.1 | -900.2 |
Biežāk uzdotie jautājumi
Kas ir Roivant Sciences Ltd. (ROIV) kopējie aktīvi?
Roivant Sciences Ltd. (ROIV) kopējie aktīvi ir 2389604000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.876.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir -1.047.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 35.091.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 39.165.
Kāda ir Roivant Sciences Ltd. (ROIV) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir -1230024000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 481404000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 1125721000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.